1.25
price up icon0.00%   0.05
 
loading
Schlusskurs vom Vortag:
$1.20
Offen:
$1.21
24-Stunden-Volumen:
2,279
Relative Volume:
0.02
Marktkapitalisierung:
$6.51M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+9.09%
1M Leistung:
-26.83%
6M Leistung:
-73.12%
1J Leistung:
-92.56%
1-Tages-Spanne:
Value
$1.17
$1.21
1-Wochen-Bereich:
Value
$0.99
$1.53
52-Wochen-Spanne:
Value
$0.97
$19.44

Traws Pharma Inc Stock (TRAW) Company Profile

Name
Firmenname
Traws Pharma Inc
Name
Telefon
267-759-3680
Name
Adresse
12 PENNS TRAIL, NEWTOWN
Name
Mitarbeiter
7
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
TRAW's Discussions on Twitter

Vergleichen Sie TRAW mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TRAW
Traws Pharma Inc
1.17 6.61M 0 0 0 0.00
Biotechnology icon
ONC
Beigene Ltd Adr
239.16 23.78B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
434.86 108.15B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.24 43.44M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
604.76 61.69B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
75.00 5.72B 0 -153.72M -103.81M -2.00

Traws Pharma Inc Stock (TRAW) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-03-01 Eingeleitet Ladenburg Thalmann Buy
2021-05-18 Eingeleitet Guggenheim Buy
2018-03-01 Bestätigt H.C. Wainwright Buy
2018-01-17 Herabstufung Maxim Group Buy → Hold
2017-10-09 Eingeleitet H.C. Wainwright Buy
2017-04-27 Eingeleitet Laidlaw Buy
2015-07-01 Hochstufung Piper Jaffray Neutral → Overweight
2015-05-05 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Traws Pharma Inc Aktie (TRAW) Neueste Nachrichten

pulisher
May 19, 2025

Traws Pharma Highlights Q1 2025 Financial Progress and Antiviral Developments - MSN

May 19, 2025
pulisher
May 19, 2025

Traws Pharma Unveils New Strategic Antiviral Focus - TipRanks

May 19, 2025
pulisher
May 16, 2025

Traws Pharma’s Q1 2025 Results Highlight Progress and Profit - TipRanks

May 16, 2025
pulisher
May 15, 2025

Traws Pharma Reports First Quarter 2025 Results And Business Highlights - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Traws Pharma Reports Q1 2025 Financial Results - TipRanks

May 15, 2025
pulisher
May 15, 2025

Traws Pharma Reports First Quarter 2025 Results and Business Highlights - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

Traws Pharma Earnings Surge to $21.5M as Former CDC Director Backs Novel Flu and COVID Drug Pipeline - Stock Titan

May 15, 2025
pulisher
May 08, 2025

Renaissance Technologies LLC Takes $89,000 Position in Traws Pharma, Inc. (NASDAQ:TRAW) - Defense World

May 08, 2025
pulisher
May 04, 2025

Geode Capital Management LLC Makes New $185,000 Investment in Traws Pharma, Inc. (NASDAQ:TRAW) - Defense World

May 04, 2025
pulisher
Apr 23, 2025

TRAW stock touches 52-week low at $1.51 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 23, 2025
pulisher
Apr 23, 2025

TRAW stock touches 52-week low at $1.51 amid sharp annual decline - Investing.com India

Apr 23, 2025
pulisher
Apr 19, 2025

Traws Pharma Appoints New Chairman Amid Leadership Changes - MSN

Apr 19, 2025
pulisher
Apr 18, 2025

Traws Pharma appoints new interim CEO with compensation details By Investing.com - Investing.com Canada

Apr 18, 2025
pulisher
Apr 18, 2025

Traws Pharma appoints new interim CEO with compensation details - Investing.com Australia

Apr 18, 2025
pulisher
Apr 08, 2025

Traws Pharma announces $50 million stock offering potential - Investing.com Australia

Apr 08, 2025
pulisher
Apr 07, 2025

Traws Pharma announces $50 million stock offering potential By Investing.com - Investing.com Canada

Apr 07, 2025
pulisher
Apr 07, 2025

Traws Pharma Announces Promising Data for Ratutrelvir as a COVID-19 Treatment - MSN

Apr 07, 2025
pulisher
Apr 05, 2025

Traws Pharma Reports 2024 Financial Results and Advances Bird Flu and COVID Programs - MSN

Apr 05, 2025
pulisher
Apr 02, 2025

TRAW stock touches 52-week low at $2.01 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 02, 2025
pulisher
Apr 02, 2025

TRAW stock touches 52-week low at $2.01 amid sharp annual decline - Investing.com India

Apr 02, 2025
pulisher
Apr 02, 2025

Traws Pharma CEO Werner Cautreels to retire - MSN

Apr 02, 2025
pulisher
Apr 01, 2025

Traws Pharma Reports 2024 Results and Strategic Progress - TipRanks

Apr 01, 2025
pulisher
Mar 31, 2025

Traws Pharma Showcases Promising COVID-19 Drug at ICAR Conference - MSN

Mar 31, 2025
pulisher
Mar 31, 2025

Earnings call transcript: Traws Pharma Q1 2025 shows innovation boost By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Earnings call transcript: Traws Pharma Q1 2025 shows innovation boost - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

Traws Pharma Announces Virtual Investor Event to Showcase Innovative Treatments for Bird Flu and COVID-19 - MSN

Mar 31, 2025
pulisher
Mar 31, 2025

Traws Pharma Reports 2024 Financial Results and CEO Change - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Traws Pharma Reports Full Year 2024 Results and Business Highlights - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Traws Pharma's Bird Flu Drug Shows Promise Despite $166M Annual LossKey Updates - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Traws Pharma (TRAW) Expected to Announce Quarterly Earnings on Monday - Defense World

Mar 31, 2025
pulisher
Mar 30, 2025

Traws Pharma Announces CEO Transition as Werner Cautreels Retires - MSN

Mar 30, 2025
pulisher
Mar 28, 2025

Traws Pharma announces CEO retirement and interim successor By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Traws Pharma announces CEO retirement and interim successor - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Traws Pharma CEO Werner Cautreels Retires, Chair Iain Duke Succeeds on Interim Basis - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

Traws Pharma Announces Management Updates - GlobeNewswire

Mar 28, 2025
pulisher
Mar 28, 2025

Leadership Shift at Traws Pharma: Chairman Steps Up as CEO Exits, Key Antiviral Programs Continue - Stock Titan

Mar 28, 2025
pulisher
Mar 28, 2025

Traws Pharma Reports Promising Preclinical Results for Bird Flu Treatment - MSN

Mar 28, 2025
pulisher
Mar 26, 2025

Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET - The Manila Times

Mar 26, 2025
pulisher
Mar 26, 2025

Traws Pharma to Host Investor Event on Bird Flu and COVID - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

Former CDC Director Unveils Game-Changing Bird Flu and COVID Treatments at Traws Pharma Event - Stock Titan

Mar 26, 2025

Finanzdaten der Traws Pharma Inc-Aktie (TRAW)

Es liegen keine Finanzdaten für Traws Pharma Inc (TRAW) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$31.59
price down icon 0.61%
$580.88
price down icon 0.56%
$4.11
price up icon 2.49%
$291.36
price down icon 0.81%
$1.7196
price up icon 32.22%
$74.91
price up icon 1.13%
Kapitalisierung:     |  Volumen (24h):